The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
CRISPR-Cas9 Technology for Precision Cancer Medicine: Target Discovery, Disease Modeling, and Therapeutics
|
|
Author(s): V. N. Pallavi (Sri Sathya Sai University for Human Excellence, India), Savitha Chowdareddy (Sri Sathya Sai University for Human Excellence, India), Bhumika Iranna Byalahunasishetter (Sri Sathya Sai University for Human Excellence, India)and Ramya Raghavan (Sri Sathya Sai University for Human Excellence, India)
Copyright: 2026
Pages: 38
Source title:
CRISPR-Cas9 Technology for Precision Medicine
Source Author(s)/Editor(s): Jen-Tsung Chen (National University of Kaohsiung, Taiwan)
DOI: 10.4018/979-8-3373-4857-5.ch002
Purchase
|
Abstract
CRISPR/Cas9 technology has emerged as a transformative tool in revolutionizing target discovery, disease modeling, and therapeutic interventions. Conventional CAR-T therapy achieves overall response rates of 70-85%, compared with 20-40% with standard chemotherapy. The technology shows particular promise in solid tumors including breast, lung, colorectal, hepatocellular, prostate, and pancreatic cancers. China, Asian nations have made substantial CRISPR contributions with mechanisms ranging from oncogene disruption to CAR-T cell enhancement. Critical ethical frameworks addressing informed consent, germline editing, off-target effects, and global access equity have been established. The 2021 WHO framework provides a normative foundation but lacks enforcement mechanisms. The interdisciplinary convergence of CRISPR with artificial intelligence, multi-omics profiling, and systems biology promises next-generation precision oncology.
Related Content
|
Kazi Asraf Ali, Rideb Chakraborty, Naureen Afrose, Chowdhury Mobaswar Hossain, Amit Kotal, Sourav Samanta.
© 2026.
34 pages.
|
|
V. N. Pallavi, Savitha Chowdareddy, Bhumika Iranna Byalahunasishetter, Ramya Raghavan.
© 2026.
38 pages.
|
|
M. Suriya, V. Aarthi, S. S. Meenambiga, P. Prakash, P. Vivek.
© 2026.
34 pages.
|
|
Kumar Ebenezar Kesavarao, Manoj Mani, Mokesh Kadhirvel, Balaji Esakkimuthu, Akilandeswari Govindraj, Jerline Babu Maria, Velayuthaprabhu Shanmugam, Vijaya Anand Arumugam.
© 2026.
40 pages.
|
|
Ajay Sharma, Pratibha Singh.
© 2026.
28 pages.
|
|
Arthi Gunasekaran, Muthupandi Vanaraj, Maria Sneha Philip Kumar, Abidharini Jothi Dheivasikamani, Arthi Boro, Antony Prabhu Jeyabal Philomenathan, Alwin Robert Asirvatham, Vijaya Anand Arumugam.
© 2026.
34 pages.
|
|
Saloua Mabsor-Zgandaoui, Khawla Rachmoune, Soumia Ed-Day.
© 2026.
30 pages.
|
|
|